Vjoncology

Advances in first-line TKIs for advanced hepatocellular carcinoma 0:40
Advances in first-line TKIs for advanced hepatocellular carcinoma VJOncology 0 1 день назад
Reevaluating treatment approaches for ER-Low TNBC 0:47
Reevaluating treatment approaches for ER-Low TNBC VJOncology 0 1 день назад
PROMENADE: highlighting TNBC in younger patients with aggressive features 1:03
PROMENADE: highlighting TNBC in younger patients with aggressive features VJOncology 0 1 день назад
The intersection of bacterial therapy and immunotherapy in cancer treatment 0:40
The intersection of bacterial therapy and immunotherapy in cancer treatment VJOncology 0 1 день назад
Engineering bacteria to enhance immunotherapy for cancer treatment 0:54
Engineering bacteria to enhance immunotherapy for cancer treatment VJOncology 0 1 день назад
Incorporating sex and gender analyses in colorectal cancer clinical trials 1:06
Incorporating sex and gender analyses in colorectal cancer clinical trials VJOncology 0 1 день назад
The role of sex and gender in colorectal cancer treatment 1:10
The role of sex and gender in colorectal cancer treatment VJOncology 0 1 день назад
Key findings on osteosarcoma treatment in the PROACH trial 2:56
Key findings on osteosarcoma treatment in the PROACH trial VJOncology 13 1 день назад
Optimizing anti-angiogenic therapies in resectable osteosarcoma 1:54
Optimizing anti-angiogenic therapies in resectable osteosarcoma VJOncology 18 1 день назад
Evolving treatment paradigms in metastatic breast cancer 1:51
Evolving treatment paradigms in metastatic breast cancer VJOncology 30 2 дня назад
Second-line treatment of mHSPC 0:38
Second-line treatment of mHSPC VJOncology 58 3 года назад
Combining radiotherapy with novel agents in NSCLC 0:47
Combining radiotherapy with novel agents in NSCLC VJOncology 77 2 года назад
Active surveillance in localized prostate cancer 4:12
Active surveillance in localized prostate cancer VJOncology 3,799 1 год назад
VJOncology at BTOG 2023 0:34
VJOncology at BTOG 2023 VJOncology 41 1 год назад
The use of photopheresis for the treatment of cutaneous T-cell lymphoma 3:22
The use of photopheresis for the treatment of cutaneous T-cell lymphoma VJOncology 1,296 8 лет назад
Advances in salvage radiotherapy for prostate cancer 1:23
Advances in salvage radiotherapy for prostate cancer VJOncology 203 4 месяца назад
Current challenges and key developments in CRC 4:00
Current challenges and key developments in CRC VJOncology 138 4 года назад
Evolving treatment paradigms in metastatic breast cancer 1:51
Evolving treatment paradigms in metastatic breast cancer VJOncology 30 2 дня назад
Hormone receptor status and tumor subtypes in BRCA-variant breast cancer 1:26
Hormone receptor status and tumor subtypes in BRCA-variant breast cancer VJOncology 90 3 месяца назад
KEYNOTE-775 subgroup analysis in advanced endometrial cancer 3:28
KEYNOTE-775 subgroup analysis in advanced endometrial cancer VJOncology 663 3 года назад
Phase Ib data CAPItello-292: capivasertib + palbociclib + fulvestrant in HR+/HER2- breast cancer 1:49
Phase Ib data CAPItello-292: capivasertib + palbociclib + fulvestrant in HR+/HER2- breast cancer VJOncology 480 1 год назад
Important biomarkers in luminal type breast cancer and DCIS 2:28
Important biomarkers in luminal type breast cancer and DCIS VJOncology 172 6 месяцев назад
Ki-67 index after neoadjuvant ET as a prognostic biomarker for HR+/HER2- early breast cancer 6:09
Ki-67 index after neoadjuvant ET as a prognostic biomarker for HR+/HER2- early breast cancer VJOncology 2,073 1 год назад
Mid-career burnout and how to overcome it 3:44
Mid-career burnout and how to overcome it VJOncology 14,279 6 лет назад
ETOP clinical trials in EGFR-, KRASG12C- and ALK-mutated NSCLC 2:47
ETOP clinical trials in EGFR-, KRASG12C- and ALK-mutated NSCLC VJOncology 156 1 год назад
The role of PSMA PET in recurrent prostate cancer 3:50
The role of PSMA PET in recurrent prostate cancer VJOncology 7,582 1 год назад
Updated analysis of DESTINY-Gastric02: T-DXd in HER2+ GEJ cancer who progressed with trastuzumab 2:58
Updated analysis of DESTINY-Gastric02: T-DXd in HER2+ GEJ cancer who progressed with trastuzumab VJOncology 135 2 года назад
Updated overall efficacy and safety of selpercatinib in patients with RET fusion+ NSCLC 2:52
Updated overall efficacy and safety of selpercatinib in patients with RET fusion+ NSCLC VJOncology 395 3 года назад
Metastatic TNBC at ESMO Breast 2024: IMpassion132 and MORPHEUS 1:05
Metastatic TNBC at ESMO Breast 2024: IMpassion132 and MORPHEUS VJOncology 193 4 месяца назад

Сейчас ищут